Citicoline in Ischemic Stroke
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.
Also called NCT05154903
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 200 participants
- Registry
-
NCT05154903
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Egypt
- Registry status
- Unknown status
Technical summary
Registry record NCT05154903. Randomized; no masking; primary purpose treatment. Start 2021-07-22 (actual); primary completion 2022-04-22 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Citicoline in Ischemic Stroke
- Condition
- Acute Ischemic Stroke
- Intervention (Drug)
- Citicoline 500 MG
- Lead sponsor
- Ain Shams University
- Collaborator
- Kafrelsheikh University
Record details
- Record id
cardio:ct-nct05154903- Content hash
43423bc941aa9766c5d37c4737ff1dfb4b7bad709bfe375b2337ecd47c692d25